$10.9 billion Monsanto Roundup settlement does not automatically shield Bayer from ‘flood’ of new glyphosate-cancer lawsuits

roundup spray
Credit: Grant Gerlock/Harvest Public Media
[Bayer] on [June 24] agreed to pay as much as $10.9 billion to end the litigation by U.S. Roundup users who say the herbicide caused them to develop a form of blood cancer.

But Bayer had to find a separate solution to mitigate the risk of future claims without pulling the product off the shelves. The company decided to make a calculated gamble on the scientific evidence which so far has overwhelmingly supported its claim that glyphosate, the active ingredient in Roundup, is safe for agricultural use.

While many details of the proposal have yet to be released by Bayer and approved by a federal judge, the plan calls for an independent panel of scientific experts, who will likely be chosen and agreed upon by both sides.

ADVERTISEMENT

The company will pay $1.25 billion to support the panel’s research …. The scientific review process is expected to take at least four years, and findings by the panel would be binding on Bayer and anyone who has used Roundup before [June 24] but not developed cancer.

Related article:  Arkansas bans dicamba herbicide use until fall following more than 1,000 crop damage complaints

If the panel finds glyphosate to be non-carcinogenic, those users could not sue. If the panel determines glyphosate causes cancer, however, Bayer could face a flood of new lawsuits…

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend